Lab tests reveal bodega weight-loss drug is contaminated bacteria and perfume filler

Key points

• CBS News purchased a vial of retatrutide from a Brooklyn bodega for $90, which University of Iowa researcher Jason Galpin confirmed contained no peptide structure.
• The bodega sample was found to contain phenylacetic acid, a compound used in perfumes and illicit amphetamine manufacturing, along with 13 bacterial colonies that pose infection risks.
• Two deaths have been linked to black-market retatrutide: a 41-year-old woman in July and a 49-year-old woman in September, both reported to the FDA via the Adverse Event Reporting System.
• Eli Lilly, the manufacturer of the experimental drug, stated that black-market sellers cannot guarantee sterility or stability, warning that consumers are gambling with their health.
• Researchers at the University of Pennsylvania analyzed 150,000 Reddit posts to identify self-reported side effects, noting that gray market formulations vary widely and cannot be verified.

Background

Retatrutide is an experimental weight-loss drug currently in clinical trials by Eli Lilly, not yet approved by the FDA. Previous coverage has highlighted the growing trend of unapproved peptides being sold through gray markets, including reports of serious injuries and deaths associated with illicit products in the UK, Ireland, and Australia. The FDA has also issued warnings regarding contaminated ingredients from Chinese manufacturers and unsanitary conditions in US compounding pharmacies.

How outlets are covering it

CBS News and Futurism emphasize the immediate danger of contaminated products, highlighting that bodega samples contained bacteria and non-peptide chemicals. In contrast, Penn Today focuses on the broader epidemiological picture, using AI to analyze Reddit discussions for side effects while cautioning that these self-reports do not prove causation due to the variability of black-market products. Partnership for Safe Medicines highlights the regulatory failures and international scale of the problem, noting that FDA inspectors found black mold and bugs in Chinese factories supplying ingredients to US compounders. Eli Lilly’s statement underscores the lack of quality control in unregulated markets, warning that a single test does not guarantee safety for future doses.

Why it matters

The ease of access to unapproved, potentially lethal substances in everyday retail environments poses a significant public health risk. The contamination of injectable drugs with bacteria and industrial chemicals highlights the dangers of bypassing medical oversight and regulatory standards, leading to severe infections and fatalities.

What to watch

Regulators are expected to increase enforcement against black-market peptide sales and compounding pharmacies with violations. Health officials continue to urge consumers to consult qualified professionals before using weight-loss drugs, while researchers monitor social media for emerging side effect patterns to inform future safety assessments.